We found that naturally occurred SMARCA4/2-deficient cancer cells are more resistant to chemotherapy, which is in line with previous reports showing that SCCOHT is typically more resistant to conventional chemotherapy in both cell models and patients15,34. The gene discussed is SMARCA4; the disease is cancer.